The heterogeneity of the COVID-19 pandemic and national responses: an explanatory mixed-methods study.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Chen YY;Chen YY; Assefa Y; Assefa Y
  • Source:
    BMC public health [BMC Public Health] 2021 May 01; Vol. 21 (1), pp. 835. Date of Electronic Publication: 2021 May 01.
  • Publication Type:
    Journal Article
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2458 (Electronic) Linking ISSN: 14712458 NLM ISO Abbreviation: BMC Public Health Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : BioMed Central, [2001-
    • Subject Terms:
    • Abstract:
      Background: The coronavirus disease of 2019 (COVID-19) has quickly spread to all corners of the world since its emergence in Wuhan, China in December of 2019. The disease burden has been heterogeneous across regions of the world, with Americas leading in cumulative cases and deaths, followed by Europe, Southeast Asia, Eastern Mediterranean, Africa and Western Pacific. Initial responses to COVID-19 also varied between governments, ranging from proactive containment to delayed intervention. Understanding these variabilities allow high burden countries to learn from low burden countries on ways to create more sustainable response plans in the future.
      Methods: This study used a mixed-methods approach to perform cross-country comparisons of pandemic responses in the United States (US), Brazil, Germany, Australia, South Korea, Thailand, New Zealand, Italy and China. These countries were selected based on their income level, relative COVID-19 burden and geographic location. To rationalize the epidemiological variability, a list of 14 indicators was established to assess the countries' preparedness, actual response, and socioeconomic and demographic profile in the context of COVID-19.
      Results: As of 1 April 2021, the US had the highest cases per million out of the nine countries, followed by Brazil, Italy, Germany, South Korea, Australia, New Zealand, Thailand and China. Meanwhile, Italy ranked first out of the nine countries' total deaths per million, followed by the US, Brazil, Germany, Australia, South Korea, New Zealand, China and Thailand. The epidemiological differences between these countries could be explained by nine indicators, and they were 1) leadership, governance and coordination of response, 2) communication, 3) community engagement, 4) multisectoral actions, 5) public health capacity, 6) universal health coverage, 7) medical services and hospital capacity, 8) demography and 9) burden of non-communicable diseases.
      Conclusion: The COVID-19 pandemic manifests varied outcomes due to differences in countries' vulnerability, preparedness and response. Our study rationalizes why South Korea, New Zealand, Thailand, Australia and China performed better than the US, Italy and Brazil. By identifying the strengths of low burden countries and weaknesses of hotspot countries, we elucidate factors constituting an effective pandemic response that can be adopted by leaders in preparation for re-emerging public health threats.
    • References:
      JAMA. 2020 Apr 7;323(13):1239-1242. (PMID: 32091533)
      Lancet Glob Health. 2018 Feb;6(2):e152-e168. (PMID: 29248365)
      J Public Health Res. 2014 Apr 24;3(1):199. (PMID: 25170508)
      Lancet. 2020 Mar 21;395(10228):931-934. (PMID: 32164834)
      Am Psychol. 2021 Apr;76(3):462-474. (PMID: 32772539)
      Health Policy. 2015 Oct;119(10):1319-29. (PMID: 26117093)
      Inter Econ. 2020;55(3):147-152. (PMID: 32536710)
      BMJ. 2020 Mar 26;368:m1222. (PMID: 32217754)
      Lancet. 2020 May 9;395(10235):1474. (PMID: 32386582)
      Int J MCH AIDS. 2020;9(2):213-216. (PMID: 32461818)
      Lancet. 2021 Jan 2;397(10268):61-67. (PMID: 33275906)
      Environ Resour Econ (Dordr). 2020;76(4):525-551. (PMID: 32836862)
      Lancet. 2020 Aug 1;396(10247):295-298. (PMID: 32628904)
      Postgrad Med J. 2020 Jul;96(1137):429-430. (PMID: 32234837)
      J Glob Health. 2020 Jun;10(1):010350. (PMID: 32426119)
      Clin Infect Dis. 2021 Jun 15;72(12):e1004-e1009. (PMID: 33252659)
      BMJ. 2020 Jun 9;369:m2296. (PMID: 32518068)
      J Health Polit Policy Law. 2020 Dec 1;45(6):967-981. (PMID: 32464658)
      BMJ. 2020 Apr 21;369:m1592. (PMID: 32317248)
      N Engl J Med. 2020 Feb 20;382(8):727-733. (PMID: 31978945)
      Glob Health Res Policy. 2020 May 7;5:22. (PMID: 32391441)
      JAMA Intern Med. 2020 Jul 1;180(7):927-928. (PMID: 32259190)
      J Stroke Cerebrovasc Dis. 2020 Sep;29(9):105089. (PMID: 32807484)
      World Dev. 2021 Jan;137:105198. (PMID: 32982017)
      Bull World Health Organ. 2012 Sep 1;90(9):664-71. (PMID: 22984311)
      Anesthesiology. 2020 Jun;132(6):1339-1345. (PMID: 32195700)
      BMJ. 2020 Jul 2;370:m2659. (PMID: 32616564)
      Glob Public Health. 2020 Sep;15(9):1413-1416. (PMID: 32564670)
      Front Med. 2020 Apr;14(2):215-219. (PMID: 32212059)
      Aging Clin Exp Res. 2020 Sep;32(9):1869-1878. (PMID: 32734576)
      Health Policy Technol. 2020 Dec;9(4):405-418. (PMID: 33520639)
      Int J Environ Res Public Health. 2020 May 12;17(10):. (PMID: 32408602)
      Polit Q. 2020 Jul-Sep;91(3):561-570. (PMID: 32836413)
      BMC Public Health. 2020 Dec 3;20(1):1853. (PMID: 33272250)
      Bull World Health Organ. 2010 Sep 1;88(9):646-7. (PMID: 20865066)
      PLoS Negl Trop Dis. 2020 Jul 6;14(7):e0008412. (PMID: 32628664)
      Health Policy. 2015 Sep;119(9):1145-52. (PMID: 26251322)
      Lancet Infect Dis. 2020 Nov;20(11):1240-1241. (PMID: 33038941)
    • Contributed Indexing:
      Keywords: Australia; Brazil; COVID-19 pandemic response; China; Germany; Italy; New Zealand; South Korea; Thailand; United States
    • Publication Date:
      Date Created: 20210502 Date Completed: 20210514 Latest Revision: 20231111
    • Publication Date:
      20240105
    • Accession Number:
      PMC8087883
    • Accession Number:
      10.1186/s12889-021-10885-8
    • Accession Number:
      33933062